'Impermeant' inhibitors of protein synthesis do not affect virally-infected cells as a result of a permeability change.
The effect of certain antiviral compounds said to act because of an increased permeability of virally infected cells has been tested in SFV-infected BHK cells. The time at which SFV-infected BHK cells become sensitive to the action of GppCH2p is more than an hour later than the time at which protein synthesis in such cells becomes depressed. The uptake of [3H]GppCH2p is the same in infected and uninfected cells, whether measured at 19 or 37 degrees C. We conclude that GppCH2p, and probably other 'impermeant' inhibitors of protein synthesis also, affect virally-infected cells selectively not because of an increased permeability, but because of a general impairment of protein synthesis in such cells.
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D002460:Cell Line; D002463:Cell Membrane Permeability; D006224:Cricetinae; D004164:Diphosphonates / Q000378:metabolism / Q000494:pharmacology*; D006150:Guanine Nucleotides / Q000494:pharmacology*; D006157:Guanosine Monophosphate / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology*; D006160:Guanosine Triphosphate / Q000031:analogs & derivatives*; D007668:Kidney; D014176:Protein Biosynthesis; D012672:Semliki forest virus; D014036:Togaviridae Infections / Q000378:metabolism; D014777:Virus Diseases / Q000378:metabolism*
D000998:Antiviral Agents; D004164:Diphosphonates; D006150:Guanine Nucleotides; C004805:5'-guanylylmethylenebisphosphonate; D006157:Guanosine Monophosphate; D006160:Guanosine Triphosphate